<b>&#x3b2;</b>-hydroxybutyrate enhances brain metabolism in normoglycemia and hyperglycemia, providing cerebroprotection in a mouse stroke model.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2025
Open on PubMed

Hyperglycemia in poorly controlled diabetes is widely recognized as detrimental to organ dysfunction. However, the acute effects of hyperglycemia on brain metabolism and function are not fully understood. The potential protective benefit of ketone bodies on mitochondrial function in the brain has also not been well characterized. Here, we evaluated the acute effects of hyperglycemia and &#x3b2;-hydroxybutyrate (BHB) on brain metabolism by employing a novel approach leveraging adenosine triphosphate (ATP)-dependence of bioluminescence originating from luciferin-luciferase activity. Oxygen consumption rate was measured in <i>ex vivo</i> live brain punches to further evaluate mitochondrial function. Our data demonstrate that brain metabolism in mice is affected by acute exposure to high glucose. This short-term effect of glucose exposure was reduced by co-administration with the ketone body BHB. Additionally, we investigated the functional relevance of BHB using an <i>in vivo</i> photothrombotic stroke model to assess its cerebroprotective effects in presence or absence of acute hyperglycemia. BHB significantly reduced infarct size in the brain stroke model, providing functional evidence for its protective role in the brain. These findings suggest that BHB may effectively mitigate the adverse effects of metabolic stress and ischemic events on brain metabolism and function.

7 Figures Extracted
Figure 1.
Figure 1. PMC
Luciferin-luciferase bioluminescence decreases in response to subcutaneous injections of high glucose (HG). (a) Experimental timeline of luciferin-luc...
Figure 2.
Figure 2. PMC
Luciferin-luciferase bioluminescence changes in response to subcutaneous injections of β-hydroxybutyrate (BHB). (a) Transgenic mice expressing lucifer...
Figure 3.
Figure 3. PMC
β-hydroxybutyrate (BHB) increases luciferin-luciferase bioluminescence in mouse brain. (a) Bar plot comparing bioluminescence in individual mice 14 mi...
Figure 4.
Figure 4. PMC
β-hydroxybutyrate (BHB) co-administered with high glucose (HG) maintains bioluminescence at control levels. (a) Bioluminescence of mice expressing luc...
Figure 5.
Figure 5. PMC
Blood glucose and ketone concentrations after subcutaneous injection of high glucose (HG) and β-hydroxybutyrate (BHB). (a) Blood glucose concentration...
Figure 6.
Figure 6. PMC
Cortical brain biopsy respiration analysis under normoglycemic and hyperglycemic conditions with and without β-hydroxybutyrate (BHB). (a) Microscopic ...
Figure 7.
Figure 7. PMC
Effect of β-hydroxybutyrate (BHB) on brain stroke infarct volume. (a) Schematic of the experimental design. Mice were injected with Rose Bengal soluti...